Acid reflux/GERD main categories:
Also included in: Pharmacy/pharmacist; gastrointestinal/Gastroenterology
Article date: 27 April 2010-14: 00 PACIFIC DAYLIGHT TIME window fbAsyncInit = function () {FB. init ({AppID: "aa16a4bf93f23f07eb33109d5f1134d3", the status is set to true, the cookie: xfbml is set to true, TRUE, channelUrl: "http://www.medicalnewstoday.com/scripts/facebooklike.html"});};(function () {var e = document.getElementById("myEditor") createElement (' script '); e. async = TRUE; e. src = document.location.protocol + "//connect.facebook.net/en_US/all.js; document.getElementById (' fb-root ') appendChild (e);}());
e-mail to friends 
reviews printer friendly
Takeda Pharmaceuticals North America, Inc. today announced that DEXILANT ™ (dexlansoprazole) delayed release capsules are now available in pharmacies in the United States (US). Takeda recently announced that the trade name of the product for dexlansoprazole in the United States will be changed from KAPIDEX ™ DEXILANT.Formulation, determination and approved dosing with DEXILANT remain the same as in KAPIDEX, which originally was approved by THE US food and Drug Administration (FDA) in January 2009. on receipt of the report, the issue of errors with KAPIDEX, Takeda, in coordination with the FDA determined that in order to preserve the safety of patients, the change of name will be the best way to minimize future errors.
DEXILANT is once daily oral medication indicated for the treatment of Heartburn associated with disease gastroesophageal reflux u-erozyjne (GERD), treatment erozyjne esophagitis (EE) and maintain a healed EE. Proton Pump cheap cialis is DEXILANT (PPI) with two editions delayed ™ (DDR) to ensure that the two separate versions of medicines.
"Takeda in response to a further situation demonstrates our commitment to the safety of patients. and we are working to ensure a smooth transition from KAPIDEX attenuate to DEXILANT to any disturbance of patient care," says Tim Rudolphi, Vice-President of marketing at Takeda."With the past few months, we can carry out a comprehensive Communication plan training of pharmacists, reaching more than 45,000 pharmacies and other healthcare professionals, including all major prescription drug wholesalers, insurers and, with the change of the name the company will start developing now these efforts also connect consumers."
"When you change the name, pharmacists are often the first group of health care, the speed of impact," noted Marlowe Ãuric Kachlic, Pharm d., Clinical Assistant Professor at the University of Illinois at Chicago College of pharmacy. "The most important for patients, pharmacists and health Note is DEXILANT the same treatment as KAPIDEX, with the same safety and efficacy profile."
Persons and health care professionals, who have questions about this change in the name of the contact Takeda at 1-877-TAKEDA-7. DEXILANT Errors or any other products should be reported to the FDA MedWatch program online at http://www.fda.gov/medwatch.
About DEXILANT ™ (dexlansoprazole) 30 mg and 60 mg delayed release capsule
Proton Pump inhibitor is DEXILANT (PPI), which reduces the production of acid by turning off many of the pumps in the stomach, thus helping to protect the oesophagus with acid reflux esophagitis, so that you can heal.DEXILANT combines the Enantiomer of two editions of lansoprazole delayed ™ (DDR) to ensure that the two separate versions of medicines.DEXILANT collected once a day, has been approved for the treatment of all species erozyjne esophagitis (EE) by a period of up to eight weeks, the maintenance of healing of EE for up to six months, and treatment of Heartburn associated with disease gastroesophageal reflux u-erozyjne (GERD) by four weeks.
Important safety information
DEXILANT is contraindicated in patients with known hypersensitivity component of the formulation.Hypersensitivity and Anaphylaxis has been reported with the use of DEXILANT. symptomatic response from DEXILANT does not preclude the presence of the Trousseau stomach.
The most commonly reported treatment emergent adverse reactions include diarrhoea (4,8%), abdominal pain (4,0%), nausea (2.9%), Upper respiratory tract infection (1.9%), vomiting (1.6%) and wzdecia (1,6%).DEXILANT cannot be co-administered with atazanavir, because the concentration of systemic atazanavir can be significantly decreased.
DEXILANT can interfere with the absorption of drugs for which the stomach pH is important for the bioavailability (e.g. ampicillin esters, Digoxin, salts of iron, ketoconazole). Taking accompanying Warfarin Patients may require monitoring growth of INR (INR) and prothrombin time increase Of prothrombin and can lead to abnormal bleeding, and even death. Use accompanying THE SIROLIMUS may increase the blood concentration of SIROLIMUS.
Source
Takeda Pharmaceuticals North America, Inc.
Note: all medical information published on this page does not have as a substitute for informed medical advice and you should not take action before consulting with a health care professional. for more information please read our terms and conditions.
All reviews are moderated before adding.
Note this publish the name of the, but we does not publish your e-mail address Only to let you know., when a message is published, we use it, not for any other purpose. read our privacy policy for more information.
If you are writing about specific medicines or operations, not professionals please care name by name.
Contact our editors News
For revisions of the factual information, or contact the editors please use our feedback form.
Please send all messages to medical or health news releases to:
Không có nhận xét nào:
Đăng nhận xét